𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Steatosis evolution is a main determinant of fibrosis progression in untreated patients with chronic hepatitis C

✍ Scribed by Laurent Castera; Christophe Hezode; Francoise Roudot-Thoraval; Anne Bastie; Elie-Serge Zafrani; Jean-Michel Pawlotsky; Daniel Dhumeaux

Book ID
118565278
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
218 KB
Volume
36
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Steatosis and progression of fibrosis in
Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection
✍ Ponni Perumalswami; David E. Kleiner; Glen Lutchman; Theo Heller; Brian Borg; Yo πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 218 KB πŸ‘ 2 views

Hepatic steatosis is common in patients with chronic hepatitis C (CHC) and is reported to be a risk factor for progression of fibrosis. The aims of this study were to evaluate the interactions between hepatic steatosis and fibrosis in a well-defined cohort of patients with CHC. The computerized path

Impact of steatosis on progression of fi
Impact of steatosis on progression of fibrosis in patients with mild hepatitis C
✍ Laetitia Fartoux; Olivier ChazouillΓ¨res; Dominique Wendum; Raoul Poupon; Lawrenc πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 119 KB πŸ‘ 2 views

In patients with mild hepatitis C, the usefulness of antiviral therapy is subject of debate, as a low risk for progression of fibrosis is assumed. Several studies have shown that steatosis is a strong and independent predictor of the severity as well as the progression of fibrosis in chronic hepatit